SCHEMBL2118864

SCHEMBL2118864

Cc1ncc(O)c(C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3396456 0.79
SCHEMBL130245 0.78
Ammonia Solution, Strong SCHEMBL15795891 0.76 NOS3 (0.39)
SCHEMBL3655582 0.75
SCHEMBL21157980 0.75
SCHEMBL27864887 0.75
SCHEMBL121166 0.75
SCHEMBL31181064 0.75
SCHEMBL26647314 0.75
SCHEMBL27384724 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119930526-A Preparation method of lebol Lei Sheng intermediate 东北制药集团股份有限公司 2025-05-06 CN claimed
CN-118994106-A Preparation method of diastereoisomer of lebol Lei Sheng 福安药业集团重庆礼邦药物开发有限公司 2024-11-22 CN claimed
CN-113214164-B Synthetic method of intermediate 2,4-dimethylpyrimidin-5-ol of Lebo Lei Sheng 广西天铭药业有限公司 2022-10-18 CN claimed
CN-113214164-A Synthetic method of Leborane intermediate 2, 4-dimethylpyrimidine-5-ol 广西天铭药业有限公司 2021-08-06 CN claimed
CN-1006792-B PROCESS FOR PREPARING HYDROXY, ALKOXYPYRIMIDINE PFIZER (US) 1990-02-14 CN claimed
CN-121574118-B Preparation method of lebo Lei Sheng 湖南迪诺制药股份有限公司 2026-05-01 CN disclosed
CN-121574118-A Preparation method of lebo Lei Sheng 湖南迪诺制药股份有限公司 2026-02-27 CN disclosed
US-20260049069-A1 METHOD AND COMPOUND USEFUL IN PREPARATION OF OREXIN-2 RECEPTOR ANTAGONIST, AND LEMBOREXANT HAVING FEW IMPURITIES EISAI R&D MAN CO LTD (JP) 2026-02-19 US disclosed
US-12479819-B2 Method and compound useful in preparation of orexin-2 receptor antagonist, and lemborexant having few impurities EISAI R&D MANAGEMENT CO., LTD. (JP) 2025-11-25 US disclosed
CN-119930526-B Preparation method of lebol Lei Sheng intermediate 东北制药集团股份有限公司 2025-07-08 CN disclosed
CN-119930526-A Preparation method of lebol Lei Sheng intermediate 东北制药集团股份有限公司 2025-05-06 CN disclosed
CN-119930526-A Preparation method of lebol Lei Sheng intermediate 东北制药集团股份有限公司 2025-05-06 CN disclosed
US-8268848-B2 Cyclopropane compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-09-18 US disclosed
US-8268848-B2 Cyclopropane compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-09-18 US disclosed
US-20120095031-A1 CYCLOPROPANE COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-04-19 US disclosed
US-20120095031-A1 CYCLOPROPANE COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-04-19 US disclosed
US-20120095031-A1 CYCLOPROPANE COMPOUND EISAI R&D MANAGEMENT CO., LTD. (JP) 2012-04-19 US disclosed
US-20080014157-A1 Skin or hair treatment agents with protective effect THE PROCTER & GAMBLE COMPANY (US) 2008-01-17 US disclosed
CN-1006792-B PROCESS FOR PREPARING HYDROXY, ALKOXYPYRIMIDINE PFIZER (US) 1990-02-14 CN disclosed
CN-86104539-A Hydroxyl and alkoxyl group miazines 1987-01-21 CN disclosed